Palisade Bio Receives Intention to Grant from European Patent Office for LB1148 Patent
March 01, 2023 09:05 ET
|
Palisade Bio, Inc.
Carlsbad, CA, March 01, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (the “Company”), a clinical stage biopharmaceutical company advancing therapies for acute and chronic...